Rapamycin improves healthspan but not inflammaging in nfκb1 (−/−) mice

Increased activation of the major pro‐inflammatory NF‐κB pathway leads to numerous age‐related diseases, including chronic liver disease (CLD). Rapamycin, an inhibitor of mTOR, extends lifespan and healthspan, potentially via suppression of inflammaging, a process which is partially dependent on NF‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Correia‐Melo, Clara, Birch, Jodie, Fielder, Edward, Rahmatika, Dina, Taylor, Jennifer, Chapman, James, Lagnado, Anthony, Carroll, Bernadette M., Miwa, Satomi, Richardson, Gavin, Jurk, Diana, Oakley, Fiona, Mann, Jelena, Mann, Derek A., Korolchuk, Viktor I., Passos, João F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351839/
https://www.ncbi.nlm.nih.gov/pubmed/30468013
http://dx.doi.org/10.1111/acel.12882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351839/
https://www.ncbi.nlm.nih.gov/pubmed/30468013
http://dx.doi.org/10.1111/acel.12882

Ejemplares similares